
Pfizer said that it will sell 10 million Covid-19 treatment courses to the US government for $5. 3 billion, pending approval from regulators. AFP
Pfizer said that it will sell 10 million Covid-19 treatment courses to the US government for $5. 3 billion, pending approval from regulators. AFP
Pfizer signs $5.3bn Covid pill deal with US
Pharmaceutical company will sell 10 million Covid-19 treatment courses to US government, pending approval from regulators
The National
November 18, 2021